This pipeline uses various statistical tests to identify selected clinical features related to mutation rate.
Testing the association between 2 variables and 8 clinical features across 248 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 1 clinical feature related to at least one variables.
-
2 variables correlated to 'HISTOLOGICAL.TYPE'.
-
MUTATIONRATE_SILENT , MUTATIONRATE_NONSYNONYMOUS
-
No variables correlated to 'Time to Death', 'AGE', 'AGE_mutation.rate', 'RADIATIONS.RADIATION.REGIMENINDICATION', 'COMPLETENESS.OF.RESECTION', 'RACE', and 'ETHNICITY'.
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant variables | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=0 | ||||
AGE | Linear Regression Analysis | N=0 | ||||
HISTOLOGICAL TYPE | Kruskal-Wallis test | N=2 | ||||
RADIATIONS RADIATION REGIMENINDICATION | Wilcoxon test | N=0 | ||||
COMPLETENESS OF RESECTION | Kruskal-Wallis test | N=0 | ||||
RACE | Kruskal-Wallis test | N=0 | ||||
ETHNICITY | Wilcoxon test | N=0 |
Time to Death | Duration (Months) | 0.6-185.8 (median=29.2) |
censored | N = 224 | |
death | N = 24 | |
Significant variables | N = 0 |
AGE | Mean (SD) | 63.09 (11) |
Significant variables | N = 0 |
AGE | Mean (SD) | 63.09 (11) |
Significant variables | N = 0 |
HISTOLOGICAL.TYPE | Labels | N |
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | 200 | |
MIXED SEROUS AND ENDOMETRIOID | 4 | |
SEROUS ENDOMETRIAL ADENOCARCINOMA | 44 | |
Significant variables | N = 2 |
No variable related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
RADIATIONS.RADIATION.REGIMENINDICATION | Labels | N |
NO | 86 | |
YES | 162 | |
Significant variables | N = 0 |
No variable related to 'COMPLETENESS.OF.RESECTION'.
COMPLETENESS.OF.RESECTION | Labels | N |
R0 | 171 | |
R1 | 11 | |
R2 | 7 | |
RX | 18 | |
Significant variables | N = 0 |
RACE | Labels | N |
AMERICAN INDIAN OR ALASKA NATIVE | 3 | |
ASIAN | 13 | |
BLACK OR AFRICAN AMERICAN | 25 | |
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | 7 | |
WHITE | 193 | |
Significant variables | N = 0 |
-
Expresson data file = UCEC-TP.patients.counts_and_rates.txt
-
Clinical data file = UCEC-TP.merged_data.txt
-
Number of patients = 248
-
Number of variables = 2
-
Number of clinical features = 8
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.